THEME
AFRAN/AFPNA 2021
The main theme of the congress this year is “Advocacy for the management of kidney disease in Africa” and several sub-themes will be discussed. On the sidelines of the congress, there will be training for general practitioners and a pre-conference on renal pathology, pediatric nephrology, clinical research, training for nurses, etc. The full program can be viewed on the congress website.
The target audience for this congress includes :
MONDAY 6th DECEMBER 2021
Exposé 1: HTA: où sommes-nous en Afrique. Euloge KRAMO (Cote d’Ivoire)
Exposé 2: Diabète, obésité: La nouvelle pandémie Africaine. Amos ANKOCHE (Cote d’Ivoire)
Exposé 3: Maladie rénale chronique en Afrique: un problème de santé publique à venir. François KAZE (Cameroun)
Exposé 1 : HTA. Kacou ANZOUAN (Cote d’Ivoire)
Exposé 2 : Diabète. Jacquot ABODO (Cote d’Ivoire)
Exposé 3 : Néphropathie diabétique. Jacques VIGAN (Benin)
Exposé 4 : Néphropathie hypertensive. Sabi KOSSI (Togo)
Exposé 1 : Les Reco internationales applicables en Afrique? Rolland N’GUETTA (Cote d’Ivoire)
Exposé 2 : Prise en charge de l'HTA en Afrique: entre réalité et reco? Ernest SOUMAILI (RD Congo)
Exposé 3 : Rôle des différents intervenants dans la prise en charge de l'HTA, Diabète et maladie CVR. Faical JARRAYA (Tunisie)
Exposé 1 : HTA et atteinte rénale de la femme enceinte. Mélanie TIA N(Cote d’Ivoire)
Exposé 2 : HTA résistante: prise en charge. Hubert YAO (Cote d’Ivoire)
Exposé 3 : HTA maligne. Gérard COULIBALY (Burkina Faso)
Réflexions à propos de l'expérience Ivoirienne. TBA
Réflexions à propos de l'expérience Tunisienne. Faical JARRAYA (Tunisie)
Echanges d'avis et conclusions
TUESDAY 7th DECEMBER 2021
Exposé 1 : La dynamique des écoles de néphrologie en Afrique francophone. Boucar DIOUF (Sénégal)
Exposé 2 : L'impact des stages pour les néphrologues africains en France (FR/AF)
Point de vue Africain : Abdou Niang (Sénégal)
Point de vue Français : Luc FRIMAT (France) Virtual
Exposé 3 : Collaborations SFNDT-AFRAN "francophones" : du concret ? Maryvonne HOURMANT (France)
Virtual
Exposé 1 : Le parcours de soins en néphrologie : l'exemple français. Luc FRIMAT (France) Virtual
Exposé 2 : Comment développer l'histologie rénale en Afrique subsaharienne. Justin NDA (Côte d’Ivoire)
Exposé 3 : Maladie rénale diabétique : une catastrophe à venir. Farid HADDOUM (Algérie)
Exposé 1 : Atteinte rénale aigue induite par Ebola. Alpha Omar BA (Guinée)
Les complications vasculo-rénales au cours de la grossesse Stanislas FAGUER (France) Virtual
Exposé 3 : L'organisation des soins intensifs en néphrologie adulte. Stanislas FAGUER (France) Virtual
Exposé 1 : Défis et perspectives de la dialyse en Afrique francophone. François KAZE. (Cameroun)
Exposé 2 : Dialyse péritonéale dans le contexte de l'Afrique Sub Saharienne : est-ce « PD first » est la solution ? ? Rasha DARWISH (Égypte)
Exposé 3 : Quid pour le développement d'un programme de transplantation en Afrique Sub- Saharienne.
Maryvonne HOURMANT (France) Virtual
MARDI 7 DECEMBRE 2021
8h30 - 9h00: Syndrome néphrotique cortico-sensible
9h00 - 9h30: Syndrome néphrotique cortico-sensible
BRUNO RANCHIN (France)9h30-10h00: Discussion
BRUNO RANCHIN (France)10h30 - 11h00: Valves de l’urethre postérieur
A BOUTY, France11h00 - 11h30: Dysfonctionnement vésical.
D. Démède(FRANCE)11h30 - 12h00: Enurésie
O. BASMAISON ,FRANCE13h30 - 14h00: CAKUT
Justine BACHETTA, France14h00 - 14h30: 0: Prise en charge des uropathies diagnostiquées en antenatal. D
Alliou Ndongo (Sénégal) ,Boa14h30 - 15h00: CAKUT en Afrique.
Kamon (Côte d’Ivoire)15h30 - 16h00: Hémodialyse chronique pédiatrique
Justine Bachetta , France Virtual16h00 - 16h30: Hémodialyse chronique et transplantation en Afrique.
A. BOURQUIA, Morocco Virtual16h30 - 17h00: Maladie rénale chronique en Afrique: Etat des lieux.
A. BOURQUIA, Morocco VirtualMARDI 7 DECEMBRE 2021
8:30-9:15 : Renal Biopsy: Bedside to microscope. Wesam ISMAIL
9 :15-9 :35 : Renal biopsy Lab: the essentials- A real life experience. Rim GOUCHA
9:35-10-00 : Questions & Discussion
10:30-11-15 Patterns of Glomerular diseases. Rim GOUCHA
11:15-11:35 Focal Segmental Glomerulosclerosis. Justin N’DAH
11:35-12:00 Infection-Related Glomerulonephritis. Wesam ISMAIL
Exposé 1 : Intertitial nephritis: a pathologic overview
Exposé 2 : Confusing cases in intersitial diseases
Exposé 3 : Case discussion
Exposé 1 : Transplantation BANF Classification revisited
Exposé 2 : Confusing cases in transplanted kidneys
Exposé 3: Case discussion
MARDI 7 DECEMBRE 2021
How to define gaps of knowledge – phrasing research questions and performing literature searches – 40 min – Registry staff
Randomised Controlled Trials (RCTs) - 20 min - Ziad Massy
Sample size calculations – 20 min - Registry staff
Challenges /obstacles/potential solutions in African countries to conduct a trial/Clinical research – 25 min African Journal of Nephrology and AFPNA Journal
Bias and confounding – 30 min – Registry staff
Causal inference versus prognosis – crucial differences in approach – 30 min – Registry staff
The art (and joy!) of scientific writing – 45 min - Registry staff
Challenges/obstacles/potential solutions in African countries to write a paper – 30 min - African Journal of Nephrology and AFPNA Journal
Discussion 15 min
How to get your paper accepted – 30 minutes – Alberto Ortiz
Challenges /obstacles/potential solutions in African countries to submit a paper – 20 minutes - African Journal of Nephrology and AFPNA Journal
General discussion 30min
MARDI 7 DECEMBRE 2021
Exposé 1 : Recommandations pour la mesure de la pression artérielle (Dr Serge KONAN)
Exposé 2 : La maladie rénale médicamenteuse : ce qu'il faut retenir r (Pr Lemrabott TALL)
Exposé 3 : Les outils d'exploration des maladies rénales : pourquoi, pour qui, et quand ? (Dr Serge KONAN)
Exposé 1 : Dysfonction d'un cathéter en cours de séance : Que faire ? (Didier BORNICHE)
Exposé 2 : Ponction et surveillance d'une FAV (Didier BORNICHE)
Exposé 3 : Désinsertion d’aiguille : Faute grave à éviter (Didier BORNICHE)
Exposé 1 : Complications aigues en hémodialyse (Didier BORNICHE)
Exposé 2 : Surveillance de la qualité de l'eau et les complications associés (Abdalah SALL)
Exposé 3 : Organisation des soins du temps de l’épidémie COVID-19 (Pr Yaya KANE)
Exposé 1 : Les immunosuppresseurs : classification (Dr Guei CYR)
Exposé 2 : introduction sur les rejets de greffons et les bases thérapeutiques (Dr Guei CYR)
Exposé 3 : règles d’hygiène à respecter face à un transplanté rénal (Dr Guei CYR)
MERCREDI 8 DECEMBRE 2021
1- PD access and complications - Brett Cullis (40min)
2- Open and laparoscopic PD catheter insertion - Henry Van Niekerk (25min)
3- Percutaneous catheter insertion and the argument for this approach in Africa- Abdou Niang (Sénégal, 20min)
4- PD access complications - Thierry Lobedez (France, 30 mins) Virtual
1- Hyponatremia: causes and management (Mohamed ABDEL GAWAD, Egypt)
2- Hyperkaliemia causes and management (François KAZE, Cameroun)
3- Metabolic acidosis: from general to tubular abnormalities. (Elliott TANNOR, Ghana) Virtual
1- Narated video of PD catheter insertion in adults- Brett Cullis (South Africa, 10 mins) Virtual
2- Narrated video of PD catheter insertion in children - Mignon McCulloch (South Africa, 20 mins) Virtual
3-Introduction of novel wireless ultrasound technology for interventional nephrologists - Moataz Fatthy (Egypt, 10 mins)Virtual
4-Trouble shooting complications (clinical cases) -Rasha Darwish (Egypt, 20 mins)
5- Paediatric case - Sampson Antwi (Ghana, 20 mins) Virtual
6- Prescribing high quality goal directed PD- Dina Abdel Latif (Egypt, 10 mins) Virtual
PD catheter insertion – practical. Abdou Niang (Senegal)/Francis Lalya (Benin) for the attendees in person
1- Technical basics of ultrasound and indications to perform a renal ultrasound. Touré BOURAÏMA ZOULIATH
2- Normal anatomic findings, normal variants and common abnormalities for a nephrologist (Menno PRUIJM) Virtual
3- Introduction of novel wireless ultrasound technology for interventional nephrologists - Moataz Fatthy (Egypt, 10 mins Virtual
program will be developed with
Developing Dialysis in low resource settings: How to set up a PD Program? Abdou NIANG- Senegal
Uremic Toxins: what’s new in 2021? Tarik SQALLI – Morocco Virtual
mini lecture: Pediatric nephrology in Africa (20 minutes) (Chris ESZEBOOR, Nigeria)
5 free communications of 10 mins each
mini lecture: Complement Disorders and Kidney diseases SFNDT
5 free communications of 10 mins each
mini lecture: When start dialysis treatment for CKD patients? (Razeen DAVIDS, South Africa) Virtual
5 free communications of 10 mins each
1- Global Kidney Health Atlas: Comparing Africa to the rest of the world. (Alain ASSOUNGA, South Africa) Virtual
2- The real word: Daily practice for a nephrologist working in an African hospital (Hussein BAGHA, Kenya)
3- kidney diseases in Africa: from 1990s to 2020s: from where we come and where we go? (Ebun BAMGBOYE (Nigeria)
1- Importance and feasibility of prevention of kidney diseases in Sub-Saharan Africa: (Ifeoma ANOCHIE, Nigeria) V
2- Collaboration between countries to advance pediatric nephrology in Africa (Hesham SAFOUH, Egypt) Virtual
3- Developing a Saving Young Lives (SYL) Program in Africa (Sampson ANTWI, Ghana). Virtual
Cultural Entertainment
Welcome addresses
Tributes
to Antony O WERE (by Ahmed TWAHIR) (5min)
to Laurence ADONIS-KOFFY (by Amal BOURQUIA) (5min)
ISN Africa Pioneer Award
Pioneer Award – background, purpose, selection process
ISN Leader – Agnes B. FOGO (5 min)
Presentation of the Pioneer Award winner’s attributes and achievements
Regional or ISN Leader - Gloria ASHUNTANTANG (5 min)
Award winner responds
Awardee – Dazé Apollinaire GNIONSAHE (5 min)
Cultural Entertainment
Inaugural lecture
kidney diseases … the following epidemic in Africa (Sarala NAIKER South Africa) (30 min) Virtual
JEUDI 9 DECEMBRE 2021
1- ISN for Africa: Hands in hands for improving nephrology care in Africa
(Gloria ASHUNTANTANG & Agnes FOGO)
2- Lecture by ISN President: Progressive Glomerulosclerosis: The Vicious Cycle Includes The Tubulointerstitium.( Agnes FOGO, USA) Virtual
3- Lecture by former ISN President: Slow or stop CKD progression: from bench to bedside (Vivekanand JHA)
1- Kidney transplantation in Africa: Living or cadaveric transplantation? Malcom DAVIS (South Africa) Virtual
2- the pediatric perspective: challenges with kidney transplantation in Africa - ways out. Mignon McCULLOCH (South Africa) Virtu
3- A kidney transplant center per country or per region in Sub-Saharan Africa? Ebun BAMGBOYE (Nigeria) Discussion
1- Which target of Blood Pressure in SSA. Are US/European Guidelines applicable? (Ernest K SUMAILI, DR Congo)
2- Atheromatous renal artery stenosis: when to check and how to treat (Menno PRUIJM) Virtual
3- RAS blockers are beneficial for black population? (Jean Baptiste ANZOUAN-KACOU, Cote d’Ivoire) Virtual
Discussion
1- Anemia in CKD patients (Jacques VIGAN, Benin)
2- Iron deficiency in CKD patients (Sabi KOSSI, Togo)
3- Bone mineral disorder and growth in pediatric patients (Justine BACHETA, France)
4- Lipid abnormalities and treatment in CKD patients (Mohamed ABDEL GAWAD, Egypt)
5- metabolic acidosis treatment: impact on CKD progression (Elliot TANNOR, Ghana)
1- MGUS and Kidney: How to manage? (Tariq SQALLI HOUSSAINI, Morocco)
2- Treatment of Lupus IV class nephropathy (Nicola WEARNE, South Africa)
3- HCV related glomerulonephritis (Mohamed Hani HAFEZ, Egypt)
4- Treatment of HIVAN (Melanie TIA, Cote d’Ivoire)
5- Renal involvement in sarcoidosis (Ahmed SOKWALA,, Kenya)
Program 1 will be developed with
program 2 will be developed with
mini lecture: FSGS & genetics with a review of the APOL1 risk alleles (Pepe EKULU)
5 free communications of 10 mins each + 2min discussion
mini lecture: Mineralocorticoid Receptor Antagonists use and benefits in CKD. (Ernest K SUMAILIDR Congo)
5 free communications of 10 mins each + 2min discussion
1- Steroid-dependent and resistant Nephrotic syndrome/Minimal Change disease for pediatrics (Hesham SAFOUH, Egypt)
2- Steroid-dependent and resistant Nephrotic syndrome/Minimal Change disease for adults (TBA, France)
3- Membranous nephropathy (Pierre RONCO ?, France)
4- FSGS (Ifeoma ULASI, Nigeria)
5- Membrano-prolifertive glomerulonephritis (Wesam ISMAIL, Egypt)
6- ANCA Crescent glomerulonephritis (Rim GOUCHA, Tunisia)
1- Coronary artery disease: when and how to check in CKD patients (Roland N’GUETTA, Cote d’Ivoire)
2- Biological markers for cardiovascular disease: the case of dialysis patients (Yewondwossen Tadesse Mengistu, Etiopia)
3- Antihypertensive treatment for dialysis patients (Faical JARRAYA, Tunisia)
4- Atrial Fibrillation in dialysis patient: how to treat? (Jean Baptiste ANZOUAN, Cote d’Ivoire)
5- New oral anticoagulation use in CKD patient (TBA, France)
6- Vitamin-K antagonist, vascular calcifications and calciphylaxis (Hesham M ELSAYED, Egypt)
Program 1 will be developed with
program 2 will be developed with
African journal of Nephrology report. Alain ASSOUNGA
African registry report. Razeen DAVIDS
AFRAN website report. Faical JARRAYA
AFRAN general secretary report. Abdou NIANG
Treasurer report. Mohamed Hani HAFEZ
VENDREDI 10 DECEMBRE 2021
1- Understanding vascular calcification in CKD patient (Ziad A. MASSY)
2- Diabetic kidney disease treatment: from bench to bedside (Christoph WANNER)
1- AKI in PICU
2- Nephrology in critically ill children
1- Radio contrast induced nephropathy: state of the art (François KAZE FOLEFACK, Cameroun)
2- Acute kidney injury in sepsis: an overview (Mohamed BENGHANEM GHARBI, Morrocco)
3- management of acute renal failure in cardiorenal syndrome (TBA, France)
1- Acute Kidney Injury Pathogenesis
2- New methods in diagnosis and management of AKI
3- Acute Kidney Injury Causes & African situation
1- Kidney involvement in COVID-19 (Saraladevi NAICKER, South Africa)
2- Management of COVID-19 patients in dialysis units. (Gloria ASHUNTANTANG, Cameroun)
3- AFRAN guidelines on COVID-19 and kidney in Africa (Hesham M ELSAYED, Egypt)
1- Cancer induced glomerular diseases. (Wissem ISMAEL, Egypt)
2- Management of multiple Myeloma with renal involvement: an update. (Tariq SQALLI HOUSSAINI, Morocco)
3- Renal complications of immune therapy (TBA, France)
Program 1 will be developed with
program 2 will be developed with
Mini lecture: Which GFR equation to use in African population? (Eric YAYO, Cote d’Ivoire)
5 free communications of 10 mins each + 2min discussion
mini lecture: Impact of epidemiological studies on public health (Kitty JAGER, Nederland)
5 free communications of 10 mins each + 2min discussion
Mini lecture: CKD-MBD after renal transplantation (Ziad A MASSY, France)
5 free communications of 10 mins each + 2min discussion
mini lecture: ….
5 free communications of 10 mins each + 2min discussion
1- 2020 KDIGO Transplant candidate guidelines (Michel JADOUL)
2- 2020 KDIGO Guidelines on diabetes in CKD (Christoph WANNER)
3- 2021 KDIGO Guidelines on Hypertension management in CKD (Michel JADOUL)
1- What to know on dialysis water processing (TBA, France)
2- Choosing dialysate parameters: for a personalized dialysis (Michel JADOUL)
3- Reuse of water rejected in dialysis: a boon in arid African countries? (Abdou NIANG, Senegal)
Should RAS blockers always be used in CKD 4-5?
Pros Menno PRUIJM
Cons Faical JARRAYA
Primary Glomerular Diseases: The new era is come! (Pierre RONCO)
20h30-24h00: AFRAN/AFPNA GALA DINNER
SAMEDI 11 DECEMBRE 2021
